Y Intercept Hong Kong Ltd Has $380,000 Stake in Proto Labs, Inc. (NYSE:PRLB)

Y Intercept Hong Kong Ltd raised its stake in Proto Labs, Inc. (NYSE:PRLB) by 22.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 12,946 shares of the industrial products company’s stock after acquiring an additional 2,356 shares during the period. Y Intercept Hong Kong Ltd owned about 0.05% of Proto Labs worth $380,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of the stock. Canada Pension Plan Investment Board bought a new position in shares of Proto Labs in the second quarter valued at approximately $37,000. Innealta Capital LLC bought a new position in Proto Labs in the 2nd quarter valued at $40,000. KBC Group NV boosted its stake in Proto Labs by 69.3% in the third quarter. KBC Group NV now owns 1,541 shares of the industrial products company’s stock worth $45,000 after purchasing an additional 631 shares in the last quarter. Meeder Asset Management Inc. bought a new stake in shares of Proto Labs during the second quarter worth $80,000. Finally, Point72 Asia Singapore Pte. Ltd. increased its stake in shares of Proto Labs by 40.6% in the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 4,108 shares of the industrial products company’s stock valued at $121,000 after buying an additional 1,186 shares in the last quarter. 84.54% of the stock is currently owned by institutional investors and hedge funds.

Proto Labs Trading Up 2.7 %

Shares of NYSE PRLB opened at $44.78 on Tuesday. Proto Labs, Inc. has a 1 year low of $25.75 and a 1 year high of $45.15. The firm’s 50-day moving average is $35.91 and its 200-day moving average is $32.38. The firm has a market capitalization of $1.10 billion, a PE ratio of 47.63 and a beta of 1.45.

Proto Labs (NYSE:PRLB) last released its earnings results on Friday, November 1st. The industrial products company reported $0.47 EPS for the quarter, topping analysts’ consensus estimates of $0.32 by $0.15. The firm had revenue of $125.60 million during the quarter, compared to analyst estimates of $121.38 million. Proto Labs had a net margin of 4.76% and a return on equity of 3.49%. The business’s quarterly revenue was down 3.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.31 EPS. As a group, equities research analysts anticipate that Proto Labs, Inc. will post 0.84 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of equities research analysts have commented on the stock. Cantor Fitzgerald reissued an “overweight” rating and set a $40.00 price objective on shares of Proto Labs in a report on Monday, November 4th. Needham & Company LLC reissued a “hold” rating on shares of Proto Labs in a research note on Friday, November 1st. Finally, Craig Hallum boosted their price objective on shares of Proto Labs from $30.00 to $36.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $40.33.

About Proto Labs

Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.